International Validation of Echocardiographic AI Amyloid Detection Algorithm

BackgroundDiagnosis of cardiac amyloidosis (CA) is often missed or delayed due to confusion with other causes of increased left ventricular wall thickness. Conventional transthoracic echocardiographic measurements like global longitudinal strain (GLS) has shown promise in distinguishing CA, but with limited specificity. We conducted a study to investigate the performance of a computer vision detection algorithm in across multiple international sites. MethodsEchoNet-LVH is a computer vision deep learning algorithm for the detection of cardiac amyloidosis based on parasternal long axis and apical-4-chamber view videos. We conducted a multi-site retrospective case-control study evaluating EchoNet-LVHs ability to distinguish between the echocardiogram studies of CA patients and controls. We reported discrimination performance with area under the receiver operating characteristic curve (AUC) and associated sensitivity, specificity, and positive predictive value at the pre-specified threshold. ResultsEchoNet-LVH had an AUC of 0.896 (95% CI 0.875 - 0.916). At pre-specified model threshold, EchoNet-LVH had a sensitivity of 0.644 (95% CI 0.601 - 0.685), specificity of 0.988 (0.978 - 0.994), positive predictive value of 0.968 (95% CI 0.944 - 0.984), and negative predictive value of 0.828 (95% CI 0.804 - 0.850). There was minimal heterogeneity in performance by site, race, sex, age, BMI, CA subtype, or ultrasound manufacturer. ConclusionEchoNet-LVH can assist with earlier and accurate diagnosis of CA. As CA is a rare disease, EchoNet-LVH is highly specific in order to maximize positive predictive value. Further work will assess whether early diagnosis results in earlier initiation of treatment in this underserved population.